Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Moses S, Elisaf"'
Autor:
Loukianos S. Rallidis, Ioannis Skoumas, Evangelos N. Liberopoulos, Charalambos Vlachopoulos, Estela Kiouri, Iosif Koutagiar, Georgia Anastasiou, Nikolaos Kosmas, Moses S. Elisaf, Dimitrios Tousoulis, Efstathios Iliodromitis
Publikováno v:
Hellenic Journal of Cardiology, Vol 61, Iss 4, Pp 241-245 (2020)
Background: In randomized clinical trials, proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) effectively reduce low-density lipoprotein-cholesterol (LDL-C) with a favorable tolerability and safety profile. Our purpose is to provide re
Externí odkaz:
https://doaj.org/article/3b9b21ac806d4147aeba29388eb1a6c1
Autor:
Antonios H. Tzamaloukas, Zeid J. Khitan, Robert H. Glew, Maria‐Eleni Roumelioti, Helbert Rondon‐Berrios, Moses S. Elisaf, Dominic S. Raj, Jonathan Owen, Yijuan Sun, Kostas C. Siamopoulos, Mark Rohrscheib, Todd S. Ing, Glen H. Murata, Joseph I. Shapiro, Deepak Malhotra
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 19 (2019)
Externí odkaz:
https://doaj.org/article/ce5a7cec08094f93ad9a9f1296e9d096
Publikováno v:
European Medical Journal Diabetes, Vol 2, Iss 1, Pp 83-87 (2014)
Patients with Type 2 diabetes mellitus (T2DM) have increased cardiovascular disease (CVD) risk. The use of statins significantly reduces the rate of CVD events but many T2DM patients, especially those with mixed dyslipidaemia (MD), have residual CVD
Externí odkaz:
https://doaj.org/article/0797db90210141518d25cec42c23ad67
Autor:
Kostas Archontogeorgis, Nikolaos Papanas, Evangelos C. Rizos, Evangelia Nena, Athanasios Zissimopoulos, Christina Tsigalou, Athanasios Voulgaris, Dimitri P. Mikhailidis, Moses S. Elisaf, Marios E. Froudarakis, Paschalis Steiropoulos
Publikováno v:
Medicina, Vol 55, Iss 5, p 174 (2019)
Background and objectives: Obstructive sleep apnea syndrome (OSAS) is associated with cardiovascular and metabolic risk factors, such as insulin resistance. Furthermore, OSAS has been associated with decreased levels of vitamin D (Vit D). The aim of
Externí odkaz:
https://doaj.org/article/dcfdb79045584827a78ddb3fe3792560
Autor:
Tycho R Tromp, Merel L Hartgers, G Kees Hovingh, Antonio J Vallejo-Vaz, Kausik K Ray, Handrean Soran, Tomas Freiberger, Stefano Bertolini, Mariko Harada-Shiba, Dirk J Blom, Frederick J Raal, Marina Cuchel, Tycho R. Tromp, Merel L. Hartgers, G. Kees Hovingh, Antonio J. Vallejo-Vaz, Kausik K. Ray, Stefano A. Bertolini, Jing Pang, Gerald F. Watts, Susanne Greber-Platzer, Martin Mäser, Thomas M. Stulnig, Christoph F. Ebenbichler, Khalid Bin Thani, David Cassiman, Olivier S. Descamps, Daisy Rymen, Peter Witters, Raul D. Santos, Liam R. Brunham, Gordon A. Francis, Jacques Genest, Robert A. Hegele, Brooke A. Kennedy, Isabelle Ruel, Mark H. Sherman, Long Jiang, Luya Wang, Željko Reiner, Vladimir Blaha, Richard Ceska, Jana Dvorakova, Lubomir Dlouhy, Pavel Horak, Vladimir Soska, Lukas Tichy, Robin Urbanek, Helena Vaverkova, Michal Vrablik, Stanislav Zemek, Lukas Zlatohlavek, Sameh Emil, Tarek Naguib, Ashraf Reda, Sophie Béliard, Eric Bruckert, Antonio Gallo, Moses S. Elisaf, Genovefa Kolovou, Hofit Cohen, Ronen Durst, Eldad J. Dann, Avishay Elis, Osama Hussein, Eran Leitersdorf, Daniel Schurr, Nitika Setia, Ishwar C. Verma, Mohammed D. Alareedh, Mutaz Al-Khnifsawi, Ali F. Abdalsahib Al-Zamili, Sabah H. Rhadi, Foaad K. Shaghee, Marcello Arca, Maurizio Averna, Andrea Bartuli, Marco Bucci, Paola S. Buonuomo, Paolo Calabrò, Sebastiano Calandra, Manuela Casula, Alberico L. Catapano, Angelo B. Cefalù, Arrigo F.G. Cicero, Sergio D'Addato, Laura D'Erasmo, Alessia Di Costanzo, Tommaso Fasano, Marta Gazzotti, Antonina Giammanco, Gabriella Iannuzzo, Anastasia Ibba, Emanuele A. Negri, Andrea Pasta, Chiara Pavanello, Livia Pisciotta, Claudio Rabacchi, Carlo Ripoli, Tiziana Sampietro, Francesco Sbrana, Fulvio Sileo, Patrizia Suppressa, Patrizia Tarugi, Chiara Trenti, Maria G. Zenti, Mika Hori, Mahmoud H. Ayesh, Sami T. Azar, Fadi F. Bitar, Akl C. Fahed, Elie M. Moubarak, Georges Nemer, Hapizah M. Nawawi, Ramón Madriz, Roopa Mehta, Arjen J. Cupido, Joep C. Defesche, M. Doortje Reijman, Jeanine E. Roeters-van Lennep, Erik S.G. Stroes, Albert Wiegman, Linda Zuurbier, Khalid Al-Waili, Fouzia Sadiq, Krzysztof Chlebus, Mafalda Bourbon, Isabel M. Gaspar, Katarina S. Lalic, Marat V. Ezhov, Andrey V. Susekov, Urh Groselj, Min-Ji Charng, Weerapan Khovidhunkit, Melih Aktan, Bulent B. Altunkeser, Sinan Demircioglu, Melis Kose, Cumali Gokce, Osman Ilhan, Meral Kayikcioglu, Leyla G. Kaynar, Irfan Kuku, Erdal Kurtoglu, Harika Okutan, Osman I. Ozcebe, Zafer Pekkolay, Saim Sag, Osman Z. Salcioglu, Ahmet Temizhan, Mustafa Yenercag, Mehmet Yilmaz, Hamiyet Yilmaz Yasar, Olena Mitchenko, Alexander R.M. Lyons, Christophe A.T. Stevens, Julie A. Brothers, Lisa C. Hudgins, Christina Nguyen, Rano Alieva, Aleksandr Shek, Doan-Loi Do, Ngoc-Thanh Kim, Hong-An Le, Thanh-Tung Le, Mai-Ngoc T. Nguyen, Thanh-Huong Truong, Dirk J. Blom, Frederick J. Raal
Publikováno v:
Homozygous Familial Hypercholesterolaemia International Clinical Collaborators 2022, ' Worldwide experience of homozygous familial hypercholesterolaemia : retrospective cohort study ', The Lancet, vol. 399, no. 10326, pp. 719-728 . https://doi.org/10.1016/S0140-6736(21)02001-8
The Lancet, 399(10326), 719-728. Elsevier Limited
The Lancet, 399(10326), 719-728. Elsevier Limited
[Background]: Homozygous familial hypercholesterolaemia (HoFH) is a rare inherited disorder resulting in extremely elevated low-density lipoprotein cholesterol levels and premature atherosclerotic cardiovascular disease (ASCVD). Current guidance abou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfdc3b132039534b5b3b16d9271de125
https://research.vumc.nl/en/publications/f39e2a3e-cdca-435e-8d43-781bf5d3735d
https://research.vumc.nl/en/publications/f39e2a3e-cdca-435e-8d43-781bf5d3735d
Publikováno v:
Vascular Health and Risk Management, Vol 2010, Iss default, Pp 525-539 (2010)
Elisavet Moutzouri, Anastazia Kei, Moses S Elisaf, Haralampos J MilionisDepartment of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, GreeceAbstract: Cardiovascular disease (CVD) represents the leading cause of mortality worl
Externí odkaz:
https://doaj.org/article/848dd32782dd446987df4fa3d38f59b8
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 6 (2015)
Objectives: To investigate the effect of benchmarking on the quality of type 2 diabetes (T2DM) care in Greece. Methods: The OPTIMISE (Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment) study [ClinicalTrials.gov identifi
Externí odkaz:
https://doaj.org/article/2f842a1ff6054a778d8cd082c34214a2
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 6 (2015)
Dapagliflozin is a selective and reversible inhibitor of sodium–glucose linked transporter type 2 (SGLT2), which mediates approximately 90% of active renal glucose reabsorption in the early proximal tubule of the kidney. Dapagliflozin significantly
Externí odkaz:
https://doaj.org/article/4b9b346c5aab4092a4a78da1f6e57e91
Publikováno v:
Diseases, Vol 5, Iss 4, p 21 (2017)
Cholesteryl ester transfer protein (CETP) inhibitors significantly increase serum high-density lipoprotein cholesterol (HDL) cholesterol levels and decrease low-density lipoprotein cholesterol (LDL) cholesterol concentration. However, three drugs of
Externí odkaz:
https://doaj.org/article/01e5787126b64a909728c7f9ba76171c
Autor:
Christos S. Derdemezis, Dimitrios N. Kiortsis, Vasilis Tsimihodimos, Maria P. Petraki, Patra Vezyraki, Moses S. Elisaf, Alexandros D. Tselepis
Publikováno v:
Biochemistry Research International, Vol 2011 (2011)
Introduction. Adipose tissue contributes to atherosclerosis with mechanisms related to adipokine secretion. Polyphenols may exhibit antiatherogenic properties. The aim of the study was to investigate the effects of three polyphenols, namely, querceti
Externí odkaz:
https://doaj.org/article/d5a24c8822a9468eafb2f5dec2063390